Cannabis Law Report

AUGUST 12, 2021

Drug Enforcement Administration’s (DEA) refusal to accommodate state and federal right to try laws. US DEA , No. RTT laws permit certain patients who have been diagnosed with life-threatening diseases or conditions access to investigational medications not yet approved for general use by the U.S. 21-70544 (9th Cir.),

DEA 105

DEA Medicine Food Patients 105

The Cannigma

JUNE 14, 2021

For more than 50 years, if you wanted to do cannabis research in the United States, federal law said you had to get the cannabis from the University of Mississippi. The BRC is among the dozens of organizations that have received preliminary approval from the DEA to cultivate cannabis. Shutterstock).

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

Cannabis Law Report

DECEMBER 7, 2021

On November 16, 2021, the Drug Enforcement Agency (DEA) issued an advance notice of proposed rulemaking , exploring whether or not to create new federal regulations governing the practice of telepharmacy. The DEA’s notice provides the industry with an opportunity to provide insight and feedback that may help shape the new regulations.

DEA 52

DEA Patients Therapy Access 52

Americans for Safe Access

APRIL 2, 2019

The Americans for Safe Access 2019 Unity Conference, themed The Price of Being a Medical Cannabis Patient, featured over a hundred patients from all over America visiting their representatives in Congress and the Senate to promote the Medical Cannabis Control Act of 2019.

Access 100

Access DEA Policy Patients 100

MJ Business Attorneys

JUNE 29, 2018

Epidiolex is the first drug the FDA has approved that contains a substance derived from marijuana, and it is also the first drug approved by the FDA to be used to treat patients with Dravet syndrome. Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. In the recent case Hemp Industries Associations v.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

Cannabis Law Report

OCTOBER 4, 2021

One of the known beneficial uses of psilocybin is as a palliative care tool for patients with advanced illness who suffer from anxiety and/or depression. Accordingly, it cannot be prescribed by a physician and it is not legally accessible to those who might benefit from it as a therapeutic treatment.

Therapy 52

Therapy Patients Law Clinical Trials 52

Cannabis Law Report

FEBRUARY 8, 2022

A new Colorado law aimed at keeping young people from buying and reselling highly potent THC concentrate has sparked concerns from doctors who recommend medical cannabis about how the new provisions could jeopardize their ability to practice medicine. It is unknown how many doctors have decided to stop working with cannabis patients.

Patients 52

Patients Legislation Concentrates DEA 52

Marijuana Lawyer Blog

JANUARY 12, 2019

As our Los Angeles marijuana patient attorneys can explain, the crux of the argument by plaintiffs of the claim, first filed in 2017, is that the designation ignores the merits of the drug for medicinal purposes. Defendants are acting-Attorney General Matthew Whitaker, the acting director of the DEA and the federal government.

DEA 40

DEA Patients Epilepsy Medicine 40

WeedAdvisor

JUNE 1, 2019

The court, citing concerns over marijuana’s Schedule I status and its impact on medical users who need it most, essentially issued an ultimatum to the DEA. Like a child who does not want to clean his or her room, the DEA simply refuses to take any major action, despite the whirlwind of reforms surrounding them on a daily basis.

DEA 55

DEA Marijuana History Cannabis 55

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. “Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”. . Most recently the FDA awarded MMJ International Holdings ?

DEA 66

DEA Clinical Trials THC Research and Development 66

Cannabis Law Report

MAY 10, 2022

Activists staged a demonstration outside of the Drug Enforcement Administration (DEA) headquarters in Virginia on Monday, demanding that the agency allow terminally ill patients to access psilocybin therapy. Patients, veterans and key advocates participated in the demonstration. Marijuana Moment reports.

DEA 52

DEA Therapy Access Patients 52

Veriheal

APRIL 11, 2022

Cannabis, despite being widely available for medical and recreational consumers across the United States, remains one of the most understudied plants. federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Drug Enforcement Agency (DEA).

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

SpeedWeed

APRIL 2, 2021

Hawaii House Approves Proposal For Cannabis Exemption From DEA. Hawaii lawmakers approved Wednesday a proposal that seeks an exemption from Drug Enforcement Administration (DEA) regulations, asking that the state is allowed to manage its medical cannabis program without federal involvement, reported Marijuana Moment.

DEA 52

DEA Programs Access Patients 52

Americans for Safe Access

JUNE 6, 2019

In July 2017, four medical cannabis patients joined other advocates in filing a lawsuit against the federal government in the U.S. Drug Enforcement Administration (DEA) to reschedule cannabis, before filing suit. District Court for the Second District of New York. The plaintiffs in the case (originally Washington v.

DEA 204

DEA Patients Cannabis 204

Veriheal

NOVEMBER 6, 2023

states and the District of Columbia currently have legal cannabis, medical or recreational. Despite this massive shift in cannabis policy, however, a few states are still dragging their feet on cannabis legalization. Idaho Idaho is one of the staunchest anti-cannabis states.

Legalization 117

Legalization Recreational THC CBD 117

Cannabis Law Report

NOVEMBER 2, 2022

Drug Enforcement Administration and the legal team representing terminally ill patients petitioning for access to psilocybin-assisted therapy. In late September, the DEA denied an official petition requesting that the agency look into rescheduling psilocybin from Schedule I to Schedule II.

Microdosing 52

Microdosing DEA Therapy Access 52

Cannabis Law Report

JULY 7, 2021

Pennington, who focuses on federal appeals and regulatory issues, is co-counsel on several high-profile cases against the DEA regarding cannabis research, hemp, and psychedelics. The INCBA supports lawyers in their practice of law as they serve all aspects of the cannabis and related industries. Hemp Industries Association v.

DEA 111

DEA Hemp Cultivation Advocacy 111

Veriheal

SEPTEMBER 13, 2022

The legal cannabis industry in the United States has slowly expanded over the last decade. Despite the federal illegality of cannabis, lawmakers and state representatives have implemented successful medical and recreational cannabis programs across the nation. Homegrown Cannabis Statistics: Supplies, Growers and Products .

Cultivation 109

Cultivation Data DEA Dispensary 109

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). The RTT Act.

DEA 52

DEA Clinical Trials Policy Research and Development 52

Veriheal

NOVEMBER 11, 2023

Many states in the US have legalized cannabis, thirty-eight states to be exact. Despite the widespread adoption, the Food and Drug Administration still classifies cannabis as a Schedule One drug. Simply put, in the eyes of federal law, cannabis is illegal. Is Medical Cannabis Legal? allow the use of medical cannabis.

Law 62

Law Chronic Pain Conditions Legislation 62

SpeedWeed

JULY 13, 2021

Governor Polis is being faced with a lawsuit over House Bill 1317, a bill that negatively affected students who were meant to benefit from the law that allows cannabis use by medical patients in public schools. . There will also be expanded tracking on purchases, and limited purchases, even for medical cannabis patients. .

Law 52

Law Patients DEA Access 52

SpeedWeed

AUGUST 16, 2021

Another iconic representative of the cannabis community, Charles Edward “Eddy” Lepp , has passed away after a battle with cancer. Army’s military intelligence unit in the Vietnam War from 1969–1972, and shortly after, became a lifelong fighter for cannabis rights. Eddy Lepp: A True Cannabis Crusader.

DEA 52

DEA Patients Therapy Cannabis 52

Veriheal

AUGUST 31, 2020

Add onto that the difficulty of these unprecedented times, as a minority-owned business, we’re making it our priority to pay it forward and invest in the future leaders of cannabis who will break barriers and pave the way for innovation in this burgeoning industry. . Veriheal’s Innovation in Cannabis Scholarship 2020 Winners .

Research and Development 117

Research and Development Education Agriculture Patients 117

The Blunt Truth

DECEMBER 29, 2023

Welcome back to The Year In Weed, The Blunt Truth’s annual roundup of cannabis-related stories. Last year , I predicted there would be no federal cannabis legalization, but that perhaps states would legalize. Virgin Islands legalized adult-use cannabis. March brought an election defeat for adult-use cannabis.

DEA 52

DEA Retail Legalization Food 52

CannaMD

SEPTEMBER 15, 2020

Current Florida medical marijuana patient? MORE DETAILS: On June 16, 2014, Florida became the 22nd state to legalize (at least partial) access to medical marijuana when Governor Rick Scott signed the Compassionate Medical Cannabis Act of 2014. Qualified patient. Thinking about getting your card? What about travel?

Law 126

Law Marijuana Patients Treatment 126

Cannabis Law Report

MAY 29, 2022

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. To mitigate safety risks, FDA implemented a Risk Evaluation and Mitigation Strategy (REMS) with elements to assure safe use (ETASU) whereby patients self-administer the spray in their healthcare provider’s office under medical supervision.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JUNE 11, 2021

In turn, here are the top 6 questions we’ve been getting lately around ketamine clinics: Isn’t the regulation of ketamine clinics just like adult-use/medicinal cannabis businesses? Pursuant to the federal Controlled Substances Act, cannabis is an illegal schedule I controlled substance while ketamine is on schedule III. No, it’s not.

Law 104

Law Compliance Compliance DEA 104

MedicalJane

JUNE 29, 2018

None of the approved drugs contain, or are derived from, the whole cannabis plant. The new drug is indicated for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. a Canada-based medical cannabis firm.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Veriheal

DECEMBER 1, 2020

Cannabis was labeled with a stigma and stereotype that is very difficult to break. Years of negative propaganda at the hands of the US federal government has painted a picture of cannabis consumers being lazy, unmotivated individuals having no motivation, drive, or desire to be good contributing members of society.

THC 52

THC DEA Research and Development Cannabinoids 52

Cannabis Law Report

MAY 2, 2019

One, the Veterans Equal Access Act, H.R. Earl Blumenauer, D-Oregon, would allow VA health providers to recommend medical marijuana to their veteran patients and fill out the necessary paperwork for them to enroll in state marijuana programs. 1647, sponsored by Rep. Full story at [link].

DEA 45

DEA Law Legislation Programs 45

Burns Levinson (Cannabusiness advisory)

OCTOBER 3, 2018

This marks the first time in history that the DEA has removed any type of cannabis from Schedule I, and clears the way for the sale of the first non-synthetic, cannabis-derived medicine to win federal approval. Therefore, it no longer meets the criteria for placement in Schedule I.

CBD 40

CBD DEA Epilepsy Pharmaceutical 40

PrestoDoctor

FEBRUARY 6, 2023

Are you interested in using medical marijuana or medical cannabis? Other states have a list of qualifying conditions that the patients must meet to get an MMJ. Finally, you will complete the application and get charged for your appointment (patients only pay if approved!). Your patient status remains confidential.

Marijuana 52

Marijuana Patients Conditions Access 52

CannaMD

MAY 6, 2020

However, given rapidly evolving – and often complicated – laws surrounding medical marijuana, many patients feel overwhelmed. Just like using medical marijuana in residential apartments , traveling with cannabis comes down to federal versus state law. For more information, see: The California Cannabis Portal. CALIFORNIA.

Hash 103

Hash Legalization Marijuana Concentrates 103

Canna Care Docs

SEPTEMBER 26, 2019

Canna Care Docs is the center of excellence for cannabis medicine. Powered by Sail, we are on a mission to solve the issue of cannabis access for patients. We’re passionate about improving our patient’s quality of life and bringing cannabis into mainstream healthcare. About Canna Care Docs….

DEA 40

DEA History Therapy Patients 40

Cannabis Law Report

DECEMBER 15, 2021

The importation of the naturally derived psilocybin into California was completed after the Company’s supply partner Mycrodose Therapeutics was granted an import license from the United States Drug Enforcement Administration (DEA). “Having a supply partner that gives us access to the rapidly growing U.S.

Supply Chain 52

Supply Chain Research and Development DEA Pharmaceutical 52

PrestoDoctor

JULY 16, 2019

Cannabis is just one case that represents the uphill battle it takes to overcome misinformation, fear, and even the hatred of groups of people, to gain sensible legislation. The gains created so far are largely credited to the work of cannabis reform groups. Prominent Cannabis Reform Groups in America and Beyond.

Policy 40

Policy DEA Access Media 40

PrestoDoctor

JULY 16, 2019

Cannabis is just one case that represents the uphill battle it takes to overcome misinformation, fear, and even the hatred of groups of people, to gain sensible legislation. The gains created so far are largely credited to the work of cannabis reform groups. Prominent Cannabis Reform Groups in America and Beyond.

Policy 40

Policy DEA Access Media 40